Register entry
Chengdu Shengnuo Biopharm Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 15
- Labeller names
- 3
- Live patents
- 0
- Countries
- 1
- Base
- China
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Chengdu Shengnuo Biopharm Co., Ltd. | No. 258, Section 1, Xueshan Avenue, Qingxia Street, Dayi County, Chengdu 611330, China (CHN) | Active ingredient (API) manufacture | 3006257504526933154 |
Catalogue
Drug listings by form and route
1515 active NDC listings: 15 bulk ingredient. By marketing category: BULK INGREDIENT 13, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 2.
| Dosage form | NDCs |
|---|---|
| powder | 15 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| chengdu shengnuo biopharm co. ltd. | 12 |
| chengdu shengnuo biopharm co., ltd. | 2 |
| chengdu shengnuo biopharm co. ltd | 1 |
Catalogue
Marketed products
15| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Abaloparatide | powder | 32861-0015BULK INGREDIENT |
| - | Eptifibatide | powder | 32861-0002BULK INGREDIENT |
| - | Ganirelix Acetate | powder | 32861-0009BULK INGREDIENT |
| - | Icatibant Acetate | powder | 32861-0004BULK INGREDIENT |
| - | Lanreotide Acetate | powder | 32861-0006BULK INGREDIENT |
| - | Linaclotide | powder | 32861-0010BULK INGREDIENT |
| - | Liraglutide | powder | 32861-0003BULK INGREDIENT |
| - | Octreotide Acetate | powder | 32861-0005BULK INGREDIENT |
| - | Semaglutide | powder | 32861-0011BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Semaglutide | powder | 32861-0014BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Teriparatide | powder | 32861-0008BULK INGREDIENT |
| - | Terlipressin Acetate | powder | 32861-0012BULK INGREDIENT |
| - | Ziconotide Acetate | powder | 32861-0007BULK INGREDIENT |
| - | bivalirudin | powder | 32861-0001BULK INGREDIENT |
| - | tirzepatide | powder | 32861-0013BULK INGREDIENT |
Compare
Comparable companies in China
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Hubei Gedian Humanwell Pharmaceutical Co., Ltd1 site · 31 NDC
- Shandong New Time Pharmaceutical Co., Ltd.1 site · 29 NDC
- Anqiu Lu'an Pharmaceutical Co., Ltd.1 site · 27 NDC
- Hainan Poly Pharm. Co., Ltd.1 site · 27 NDC
- Shenzhen Alvantis Pharma Co., Ltd.1 site · 27 NDC
- El-Peptido (Shanghai) Biopharmaceutical Co., Ltd1 site · 25 NDC
- Amphastar Nanjing Pharmaceuticals, Inc.1 site · 24 NDC
- Zhejiang Apeloa Jiayuan Pharmaceutical Co Ltd1 site · 23 NDC
Enquiry
Common questions
- Is Chengdu Shengnuo Biopharm Co., Ltd. FDA approved?
- Chengdu Shengnuo Biopharm Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Chengdu Shengnuo Biopharm Co., Ltd.'s drugs manufactured?
- The FDA register lists Dayi County. Registered operations: active ingredient (API) manufacture.
- What drugs does Chengdu Shengnuo Biopharm Co., Ltd. make?
- 15 products are listed under Chengdu Shengnuo Biopharm Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.